VPRO

Viropro Inc. VPRO

VPRO
Viropro Inc. NNBP
Nanobac Pharmaceuticals, Incorporated MCRT
Microart Inc. HAVLF
HAVN Life Sciences Inc. CLABF
Core One Labs Inc. KLDO
Kaleido Biosciences, Inc. CBDX
Curative Biosciences, Inc. AZFL
Amazonas Florestal, Ltd GMVDF
G Medical Innovations Holdings Ltd ONPH
Oncology Pharma Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode VPRO NNBP MCRT HAVLF CLABF KLDO CBDX AZFL GMVDF ONPH
6M -80.00 % 0.00 % 0.00 % -90.00 % -99.89 % 400.00 % 0.00 % 0.00 % -50.00 % 600.00 %
YTD -80.00 % 0.00 % 0.00 % -90.00 % -99.83 % 400.00 % 0.00 % 9 900.00 % -50.00 % 600.00 %
1Y -80.00 % 0.00 % 0.00 % 0.00 % -99.91 % 400.00 % 0.00 % 9 900.00 % -50.00 % 69 900.00 %
3Y -80.00 % 0.00 % 1 900.00 % -99.81 % -99.98 % -54.55 % -90.00 % -66.67 % -100.00 % -99.82 %
5Y -96.88 % -85.71 % -80.00 % -100.00 % -100.00 % -99.99 % -90.00 % 0.00 % -100.00 % -99.83 %
10Y -99.05 % -50.00 % -99.00 % -100.00 % -100.00 % -100.00 % -98.31 % -99.90 % -100.00 % -100.00 %
From the beginning -100.00 % -100.00 % -99.96 % -100.00 % -100.00 % -100.00 % -100.00 % -100.00 % -100.00 % -100.00 %

Dividend